SAFE Act
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The SAFE Act (H.R. 9416) is a bill introduced in the 118th Congress, referred to the House Committees on Energy and Commerce and Judiciary for consideration. The bill falls under the health policy area. As of the latest update on August 27, 2024, the bill has not advanced beyond committee referral and is currently classified as failed or expired. No official summary or full text of the bill is publicly available, limiting detailed analysis of its provisions.
H.R. 9416, the SAFE Act, is a health-related bill that was referred to relevant committees but did not progress further and is now considered failed or expired, with no detailed public information on its content.
- The bill is titled the SAFE Act and was introduced in the House during the 118th Congress.
- It was referred to the Committees on Energy and Commerce and Judiciary for consideration.
- The bill is categorized under the health policy area but lacks an official summary and full text for detailed review.
['Potential beneficiaries cannot be specifically identified due to the absence of bill text and summary.', 'Generally, stakeholders in the health sector could be involved given the policy area classification.']
["Lack of publicly available bill text and summary limits transparency and understanding of the bill's scope and impact.", "The bill's failure to advance past committee referral indicates possible challenges in garnering legislative support.", 'Without details, it is unclear what authority, funding, or enforcement mechanisms the bill proposes.']
The SAFE Act was introduced in the House and referred to two committees with jurisdiction over health and legal matters. The referral process is a standard legislative step for bills requiring detailed review. The bill did not move forward and is now marked as failed or expired, reflecting the legislative process where many bills do not advance to enactment.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['The failure of the bill to advance may delay or prevent potential health policy changes that the bill intended to address.', "Stakeholders interested in the bill's subject matter may need to seek alternative legislative avenues or advocacy strategies."]
The absence of an official summary and full text for H.R. 9416 limits transparency and public oversight. Tracking bills through committee referrals without detailed content restricts the ability to evaluate policy impacts or hold sponsors accountable. Improved disclosure of bill content at introduction would enhance legislative transparency.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.